Structures of langya virus fusion protein ectodomain and immunogenic compositions derived therefrom
US-2024358817-A1 · Oct 31, 2024 · US
US9417190B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9417190-B2 |
| Application number | US-201313945661-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 18, 2013 |
| Priority date | Sep 23, 2008 |
| Publication date | Aug 16, 2016 |
| Grant date | Aug 16, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
System, including methods and apparatus, for performing droplet-based assays that are controlled and/or calibrated using signals detected from droplets.
Opening claim text (preview).
We claim: 1. A method of performing a droplet-based assay, comprising: forming droplets from a same mixture, wherein only a subset of the droplets contain a target; irradiating a region of a channel; detecting a forward scattering signal and a fluorescence signal from a plurality of the droplets as each droplet passes through the region of the channel, wherein the fluorescence signal is detected from a label present in each droplet and varies according to whether the target is present in the droplet; identifying accepted droplets of the plurality for which the forward scattering signal meets a condition and rejected droplets of the plurality for which the forward scattering signal does not meet the condition, wherein the condition corresponds to a permitted size of a droplet; and determining a concentration of the target based on the fluorescence signal from the accepted droplets, and without any contribution of the fluorescence signal from the rejected droplets. 2. The method of claim 1 , wherein the forward scattering signal has an intensity that is at least substantially independent of whether or not the target is present in the droplet. 3. The method of claim 1 , wherein the forward scattering signal detected from each droplet forms a peak, and wherein the condition corresponds to a permitted width of the peak. 4. The method of claim 1 , wherein the step of determining includes a step of determining a fraction of the accepted droplets that are positive or a fraction that are negative for the target. 5. The method of claim 1 , wherein the forward scattering signal is produced by refraction of incident radiation.
Validating, e.g. range invalidation, suspending operation · CPC title
Spatial resolved fluorescence measurements; Imaging · CPC title
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction · CPC title
with two or more labels · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.